Assembly Biosciences (ASMB) Amortizatization of Intangibles (2010 - 2018)

Assembly Biosciences (ASMB) recorded quarterly Amortizatization of Intangibles of $461320.0 in Q4 2018, down 20.09% quarter-over-quarter from $577300.0 in Q4 2017, and down 20.09% on a YoY basis from $577300.0 in Q4 2017.

Assembly Biosciences (ASMB) Amortizatization of Intangibles (2010 - 2018) Analysis & Trends

Assembly Biosciences' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $461320.0 for Q4 2018.

  • In Q4 2018, Amortizatization of Intangibles fell 20.09% year-over-year to $461320.0; the TTM figure through Dec 2018 stood at $1.8 million (changed N/A YoY), while the FY2018 annual figure was $229000.0, changed N/A from the prior year.
  • Amortizatization of Intangibles was $461320.0 for Q4 2018 at Assembly Biosciences, down from $577300.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $577300.0 in Q4 2017 to a low of $461320.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Assembly Biosciences 418.96 Mn 192.36 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 461,320.00
Dec 31, 2018 461,320.00
Dec 31, 2017 577,300.00
Dec 31, 2017 577,300.00
Jun 30, 2011 24,512.00
Jun 30, 2011 24,512.00
Jun 30, 2010 784,787.00
Jun 30, 2010 784,787.00